Delivery Order SPE2DB24D1006-SPE2DB24FCEKL

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product TIVICAY 50 MG TABLET 30S. The contract is a firm fixed-price delivery order valued at $38,585.36, with a period of performance through September 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of TIVICAY 50 MG TABLET 30S. The contract has a ceiling value of $2,294.48 and an ultimate completion date of January 3, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $5,485.89 and a period of performance through September 6, 2024. It is a firm-fixed-price contract type. The contract does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen is a significant supplier of medical products and medications to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565940885 - TIVICAY 50 MG TABLET 30S. The contract has a ceiling value of $59,573.80 and a completion date of September 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,452.24, is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of April 19, 2023. This contract award is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TIVICAY 50 MG TABLET 30S. The contract has a ceiling value of $21,643.98 and an ultimate completion date of August 15, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice...
This is a $27,890.73 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 MG TABLET 30S. The contract has a period of performance through July 31, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded this delivery order as part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is a delivery order with a ceiling value of $13,191.34, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a medication, with a performance period ending on April 18, 2023. The contract is a firm fixed-price arrangement and was awarded on April 17, 2023, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,334.31 firm fixed price contract is for the supply of 4567292425 TIVICAY 50 MG TABLET 30S, which are prescription medications. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,424.48, is for the delivery of TIVICAY 50 MG TABLET 30S and has an ultimate completion date of January 23, 2025. The contract is not designated with a set-aside status, indicating open competition. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB24FCEKL
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $13,611.47 and an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to support various government agencies and healthcare programs. This particular award is not set aside and is part of a larger IDC valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure essential pharmaceutical and medical supplies from AmerisourceBergen for military treatment programs and facilities worldwide.

Generated 11/21/24, 9:29 AM